在患有糖尿病足的患者中,炎症标志物和贫血之间的关联
Jiawei Li1, Wenzhuan Chen2, Xueman Wen3
1Department of Clinical Nutrition, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Biomarkers in medicine
|November 13, 2024
概括
像IL-6和C反应蛋白 (CRP) 这样的炎症指标与糖尿病足 (DFU) 患者的炎症性贫血 (AI) 有关. 这些标志物的高水平增加了DFU病例中的贫血风险.
科学领域:
- 医学科学 医学科学 医学科学
- 临床研究 临床研究
- 炎症和免疫学 炎症和免疫学
背景情况:
- 炎症性贫血 (AI) 是患有糖尿病足 (DFU) 的患者经常出现的并发症.
- 了解DFU中炎症和贫血之间的关系对于有效的患者管理至关重要.
- 糖尿病足代表着严重的健康负担,通常与慢性炎症和贫血等并发症有关.
研究的目的:
- 调查糖尿病足患者中关键炎症指标和贫血患病率之间的特定关系.
- 在DFU人口中探索炎症标志物 (IL-6,CRP) 和贫血之间的非线性关联.
- 确定炎症作为DFU中贫血的潜在独立风险因素.
主要方法:
- 在2018年至2023年期间,一项涉及395名糖尿病足患者 (瓦格纳等级2-4) 的横截面研究进行了.
- 在开始治疗之前收集了临床数据,包括炎症标志物和贫血状态.
- 使用受限立方脊柱回归分析来评估炎症指标和贫血之间的非线性关系.
主要成果:
- 在63.54%的DFU患者中存在贫血,主要是正常细胞低染色贫血.
- 升高的干白素-6 (IL-6) 水平与贫血的几率增加有显著的相关性 (OR = 4.84).
- 高C-反应蛋白 (CRP) 水平与较高的贫血患病率 (OR = 5.01) 密切相关,观察到非线性关联,表明潜在的贫血触发因素在53.889 mg/l以上.
结论:
- 炎症被证实是导致糖尿病足患者炎症贫血的独立风险因素.
- 无论是CRP和IL-6水平都显示出L形非线性相关性与DFU中的贫血.
- 这些发现强调了监测炎症标志物的重要性,以评估DFU管理中的贫血风险.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
60
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
60
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
319
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
319


